Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction

Open access
Stahrenberg, Raoul, Edelmann, Frank, Mende, Meinhard, Kockskämper, Anke, Düngen, Hans-Dirk, Lüers, Claus, Binder, Lutz, Herrmann-Lingen, Christoph, Gelbrich, Götz, Hasenfuß, Gerd, Pieske, Burkert, Wachter, Rolf · 2010 · European Journal of Heart Failure

Abstract

Aims: Heart failure with normal ejection fraction (HFnEF) is an important clinical entity that remains incompletely understood. The novel biomarker growth differentiation factor 15 (GDF-15) is elevated in systolic heart failure (HFrEF) and is predictive of an adverse outcome. We investigated the clinical relevance of GDF-15 plasma levels in HFnEF. Methods and results: A subgroup of patients from the ongoing DIAST-CHF observational trial, with a history of chronic heart failure (CHF) or positive Framingham criteria at presentation, was selected. Patients were classified as having either HFrEF (n = 86) or HFnEF (n = 142) and compared with healthy elderly controls (n = 188) from the same cohort. Growth differentiation factor 15 levels in HFnEF were significantly higher than in controls and similar to those in HFrEF. In multivariate analysis, factors significantly associated with GDF-15 levels were age, sex, estimated glomerular filtration rate (eGFR), presence of HFrEF and HFnEF. Growth differentiation factor 15 correlated with multiple echocardiographic markers of diastolic function and was associated with 6 min walk test performance and SF-36 physical score on multivariate analysis in all patients. When using a classification for HFnEF that did not employ N-terminal pro brain natriuretic peptide (NT-proBNP) as a diagnostic criterion, the diagnostic properties of GDF-15 for detecting HFnEF tended to be superior to those of NT-proBNP, and a combination significantly improved diagnostic accuracy. Conclusion: Growth differentiation factor 15 is elevated in HFnEF to a similar degree as in HFrEF. It is independently associated with impairment in exercise capacity and in physical components of quality of life. Diagnostic precision of GDF-15 is at least as good as that of NT-proBNP and combining both markers improves diagnostic accuracy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfq151

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 161

Metadata

Authors
Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H.-D., Lüers, C., Binder, L., Herrmann-Lingen, C., Gelbrich, G., Hasenfuß, G., Pieske, B., & Wachter, R.
Venue
European Journal of Heart Failure
Published
2010-12-01
Volume
12
Issue
12
Pages
1309-1316
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2112099244
Cited by
161
References
9
FWCI
6.22
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction. https://app.cochat.ai/papers/10.1093/eurjhf/hfq151
The paper
Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H.-D., Lüers, C., Binder, L., Herrmann-Lingen, C., Gelbrich, G., Hasenfuß, G., Pieske, B., & Wachter, R. (2010). The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfq151

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.